EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Yelda Su iD, Pieter A van Doorn iD, Bart C Jacobs iD, Krista Kuitwaard iD

Journal of the Peripheral Nervous System · 2026

DOI: 10.1111/jns.70159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2026. Verfasst von Yelda Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Erasmus MC, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Immunoglobulins, Intravenous, Immunologic Factors, Immunoglobulins. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Subcutaneous immunoglobulin (SCIg) is an alternative maintenance therapy to intravenous immunoglobulin (IVIg) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The CIDP guideline considers switching from IVIg to SCIg at an equivalent dosage reasonable; however, the optimal dosing strategy is unknown. This case series examines whether a 1:1 IVIg‐to‐SCIg switch maintains clinical stability.

Methods

IVIg‐dependent, clinically stable CIDP patients who switched from IVIg to SCIg in the Erasmus Medical Center were retrospectively evaluated. Clinical deterioration was defined as a decline in grip strength or muscle strength, or an increase in disability based on minimal clinically important difference criteria within 4 months after the switch.

Results

A total of 10 consecutive CIDP patients on stable IVIg regimens switched to an equivalent (1:1) SCIg dose. One patient remained clinically stable, while nine patients deteriorated. Three of these became clinically stable after increasing the SCIg dose to 1:1.3 or 1:1.5, whereas three patients did not regain stability despite a dose increase to 1:1.3. Clinical stability was maintained in the patient receiving a low dose (0.4 g/kg every 3 weeks), whereas patients receiving higher doses (≥ 1 g/kg every 3 weeks) deteriorated. Five patients switched back to IVIg, while five remained on SCIg throughout follow‐up.

Interpretation

A 1:1 IVIg‐to‐SCIg switch was insufficient to maintain clinical stability in most CIDP patients, including those on higher IVIg maintenance doses. Some but not all patients regained stability after increasing the SCIg dose. Optimal dose adjustment strategies, including whether temporary higher dosing is required, remain to be determined in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingImmunoglobulins, IntravenousImmunologic FactorsImmunoglobulinsDrug SubstitutionHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultInjections, Subcutaneous

Stichwörter der Autor:innen

chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)dose–responseintravenous immunoglobulins (IVIg)subcutaneous immunoglobulins (SCIg)treatment response

Substanzen

Immunoglobulins, IntravenousImmunologic FactorsImmunoglobulins

Autor:innen und Institutionen

  • Department of Neurology, Erasmus MC, Rotterdam, the Netherlands.
  • Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.

ORCID-Profile: Yelda Su, Pieter A van Doorn, Bart C Jacobs, Krista Kuitwaard

Zitieren

APA

Su, Y., van Doorn, P. A., Jacobs, B. C., & Kuitwaard, K. (2026). Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70159

Vancouver

Su Y, van Doorn PA, Jacobs BC, Kuitwaard K. Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Journal of the Peripheral Nervous System. 2026. doi:10.1111/jns.70159

BibTeX
@article{Su2026,
  author = {Su, Yelda and van Doorn, Pieter A and Jacobs, Bart C and Kuitwaard, Krista},
  title = {Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  doi = {10.1111/jns.70159}
}
Kostenlos starten →